Lupin Gains USFDA Approval for Generic Doxycycline Antibacterial Injection

Indian pharmaceutical giant, Lupin Limited, has recently received a significant nod from the US Food and Drug Administration for their generic Doxycycline injection. This approval paves the way for Lupin to distribute this vital antibacterial medication in the US, offering a cost-effective alternative to Pfizer Inc's Vibramycin.